Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bio-Gene Technology Ltd. ( (AU:BGT) ) has provided an announcement.
Bio-Gene Technology Limited has completed a review of its continuous disclosure procedures following a directive from the ASX. The review led to the revision of its Communication and Disclosure Policy, the implementation of a comprehensive pre-clearance process for scientific data, and enhanced compliance training for key personnel. These measures aim to ensure that market-sensitive information is disclosed appropriately, maintaining compliance with ASX Listing Rules and enhancing the company’s operational transparency.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Limited is an Australian company specializing in the development of novel bio-insecticides aimed at addressing global challenges related to insecticide resistance. The company’s products, based on naturally occurring compounds, are designed to control pests effectively while minimizing impacts on human health and the environment. Bio-Gene’s offerings have applications in crop protection, grain storage, public health, and consumer uses, providing safe pest management solutions.
Average Trading Volume: 706,192
Technical Sentiment Signal: Hold
Current Market Cap: A$7.93M
For a thorough assessment of BGT stock, go to TipRanks’ Stock Analysis page.